SCHEMBL9084192

SCHEMBL9084192

NC(CC1CCCNC1)(P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPN1 P15169 1/20 0.39
CPB2 Q96IY4 1/20 0.39
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
ATM Q13315 1/20 0.37
CYP2D6 P10635 1/20 0.37
FDPS P14324 4/20 0.36
EPHX1 P07099 1/20 0.35
SLC6A1 P30531 4/20 0.34
SLC6A11 P48066 3/20 0.34
SLC6A13 Q9NSD5 3/20 0.34
TSHR P16473 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
APLNR P35414 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRB2 P47870 2/20 0.33
SLC6A12 P48065 2/20 0.33
NOS2 P35228 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8701605 0.83 FDPS (0.51) CPN1CPB2KMT2AKDM4EMAPT
SCHEMBL8706215 0.81 FDPS (0.50) CPN1CPB2KMT2AKDM4EMAPT
SCHEMBL9085173 0.80 CPN1 (0.39) CPN1CPB2KMT2AKDM4EMAPT
SCHEMBL9082307 0.79 ANPEP (0.44) CPN1CPB2KMT2AFDPSSLC6A1
SCHEMBL7860079 0.76 CPN1 (0.42) CPN1CPB2KMT2AKDM4EMAPT
SCHEMBL8706218 0.76 FDPS (0.42) CPN1CPB2KMT2AKDM4EMAPT
SCHEMBL8712585 0.75 CPN1 (0.35) CPN1CPB2KMT2AKDM4EMAPT
SCHEMBL9806687 0.74 FDPS (0.49) FDPSSLC6A1SLC6A11SLC6A13LMNA
SCHEMBL9084709 0.73 KMT2A (0.42) CPN1CPB2KMT2AFDPSEPHX1
Iodide SCHEMBL9163644 0.73 FDPS (0.39) CPN1CPB2KMT2AFDPSEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5519013-A Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism THE PROCTER & GAMBLE COMPANY (US) 1996-05-21 US disclosed
US-5334586-A Heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism PROCTER & GAMPLE PHARMACEUTICALS, INC. (US) 1994-08-02 US disclosed
EP-0274158-B1 Novel heterocycle-substituted diphosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate matabolism NORWICH EATON PHARMA (US) 1994-03-23 EP disclosed
EP-0586521-A1 CALCIUM, TRACE MINERAL, VITAMIN D AND DRUG THERAPY COMBINATIONS THE PROCTER & GAMBLE COMPANY (US) 1994-03-16 EP disclosed
WO-1992021355-A1 CALCIUM, TRACE MINERAL, VITAMIN D AND DRUG THERAPY COMBINATIONS THE PROCTER & GAMBLE COMPANY (US) 1992-12-10 WO disclosed
US-5071840-A Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism NORWICH EATON PHARMACEUTICALS, INC. (US) 1991-12-10 US disclosed
EP-0351897-A2 Skin penetration system for salts of amine-functional drugs THE PROCTER & GAMBLE COMPANY (US) 1990-01-24 EP disclosed